Difference between revisions of "NGS"

(Created page with "Next Generation Sequencing (NGS) is an interesting technology for PGx A nice overview of the [https://doi.org/10.2217/pgs-2016-0023 Requirements for comprehensive pharmacogen...")
 
Line 1: Line 1:
 
Next Generation Sequencing (NGS) is an interesting technology for PGx
 
Next Generation Sequencing (NGS) is an interesting technology for PGx
  
A nice overview of the [https://doi.org/10.2217/pgs-2016-0023 Requirements for comprehensive pharmacogenetic genotyping platforms] was published by _Volker Lauschke et al._ They claim that rare variants account for 30-40% of functional variability in PGx. However they argue that pre-emptive PGx should only include validated variants.
+
A nice overview of the [https://doi.org/10.2217/pgs-2016-0023 Requirements for comprehensive pharmacogenetic genotyping platforms] was published by ''Volker Lauschke et al.'' They claim that rare variants account for 30-40% of functional variability in PGx. However they argue that pre-emptive PGx should only include validated variants.
  
 
==Challenges==
 
==Challenges==
* Short read NGS requires a priori knowledge of likelihood of particular haplotypes. _In silico_ haplotype estimation can e.g. be performed by [http://faculty.washington.edu/browning/beagle/beagle.html Beagle].
+
* Short read NGS requires a priori knowledge of likelihood of particular haplotypes. ''In silico'' haplotype estimation can e.g. be performed by [http://faculty.washington.edu/browning/beagle/beagle.html Beagle].
 
* Variants in homologous regions are hard to capture.
 
* Variants in homologous regions are hard to capture.

Revision as of 15:11, 13 August 2018

Next Generation Sequencing (NGS) is an interesting technology for PGx

A nice overview of the Requirements for comprehensive pharmacogenetic genotyping platforms was published by Volker Lauschke et al. They claim that rare variants account for 30-40% of functional variability in PGx. However they argue that pre-emptive PGx should only include validated variants.

Challenges

  • Short read NGS requires a priori knowledge of likelihood of particular haplotypes. In silico haplotype estimation can e.g. be performed by Beagle.
  • Variants in homologous regions are hard to capture.